Daily Dose: NAFLD Associated with Adverse Outcomes Regardless of BMI
Your daily dose of the clinical news you may have missed.
Fibrosis Screening Results May Motivate Behavior Change in Adults at Risk of Liver Disease: Danish Study
Screening for fibrosis in persons at risk of ALD and MASLD led to sustained improvements in lifestyle, eg, reduced alcohol consumption, weight loss, and increased exercise.
The Role of Biomarkers for Management of Crohn Disease: A Guideline Topline
The American College of Gastroenterology's new guidelines focus on improved prognosis through early detection, improved accuracy in monitoring,
Consuming More Food, Beverages with Added Sugar Linked to Greater Risk for Metabolic Syndrome
Compared to the lowest intake of AS-rich food and beverages, the highest intake was associated with a 59% higher risk of developing MetS, according to new findings.
Ustekinumab Maintenance Therapy for Ulcerative Colitis Safe, Effective at 4 Years: UNIFI-LTE
More than half of adults with moderate to severe UC maintained clinical and endoscopic remission at 4 years; nearly all no longer required corticosteroids, authors reported.
Daily Dose: Frequent Addition of Salt to Food Raises Risk of CKD
Vaccination Still the Best Defense Against Long COVID: CDC Recommendations in Brief
The best defense against long COVID remains COVID-19 vaccination. This short slide show highlights long COVID symptoms and CDC vaccination recommendations.
FDA Review Suggest No Link Between GLP-1RAs and Suicidal Thoughts but Surveillance Will Continue
While the FDA's preliminary evaluation has not surfaced evidence of a link, the agency says it "cannot definitively rule out that a small risk may exist," and so will continue research.
Screening and Treatment for Osteoporosis Lacking for Persons with Cirrhosis, According to Real-World Analysis
Less than a quarter of persons with cirrhosis who are diagnosed with osteoporosis are started on treatment, reported researchers.
Daily Dose: High BMI in Adolescence Linked to CKD in Young Adulthood
Nonpharmacologic Therapies for Neuropathic Pain in Older Adults
A recent review analyzed the effectiveness of nonpharmacologic therapies for neuropathic pain in older adults. Results in our new slide show.
ACG Releases New Clinical Guideline for Management of Alcohol-Associated Liver Disease
The new guideline underscores the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with ALD.
Dupilumab Reduces Nighttime Symptoms, Sleep Disturbance in Severe T2 Asthma
Use of dupilumab also eliminated the need for use of a rescue inhaler in more than one-third of treated patients and the number of inhalations needed for others.
Milvexian Added to Standard DAPT Fails to Reduce Stroke Risk, May Increase Risk of Bleeding
AXIOMATIC-SSP is considered the largest clinical trial of activated factor XIa inhibition added to standard antiplatelet therapy for secondary stroke prevention.
Semaglutide Linked to Lower Risk of Suicidal Ideation in Patients with Obesity, Type 2 Diabetes
Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.
COPD Exacerbations May Increase Risk of Severe CV Events by More Than 15-Fold: Cohort Study
The risk of severe CV events, including leading to death, was greatest in the first week following an exacerbation but remained significantly elevated 1 year later.
Obesity Management: What Clinicians Need to Know in 2024
Angela Fitch, MD, president of the Obesity Medicine Association, details what to look forward to this year in terms of obesity management.
Colorectal Cancer Incidence Has Increased Among Younger Men, Not Women, According to Recent Study
Data from recent Austrian study suggest that sex should be considered when determining screening age for colorectal cancer, reported authors.
Daily Dose: Higher Omega-3 Fatty Acid Intake May Slow Pulmonary Fibrosis Disease Progression
Elinzanetant Meets Safety, Efficacy Endpoints in Phase 3 Studies Of Menopausal VMS
The novel nonhormonal compound significantly reduced vasomotor symptoms and sleep disturbance while improving quality of life, according to findings.
